Apr 18 |
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
|
Apr 12 |
IMNN: IND Application Submitted for Phase 1/2 Trial of Seasonal COVID-19 Vaccine…
|
Apr 11 |
IMUNON regains compliance with Nasdaq's listing rule
|
Apr 11 |
IMUNON Reports Compliance with Nasdaq Listing Requirements
|
Apr 10 |
Imunon files to withdraw registration statement
|
Apr 1 |
Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Imunon, Inc. (IMNN) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Imunon GAAP EPS of -$2.16 beats by $0.07
|
Mar 28 |
IMUNON Reports 2023 Financial Results and Provides Business Update
|
Mar 28 |
Earnings Scheduled For March 28, 2024
|